ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

Review PT Avia Avian Tbk (AVIA:XIDX) stock and the current sustainability and ESG risk rating to help with your investing decisions.

AbbVie is also trying to extend the indications for the FRα-targeting antibody-drug conjugate (ADC), with a phase 3 study on the go in platinum-sensitive ovarian cancer, and will also be tested ...

High-grade serous ovarian cancer, the most common form of the disease, is often fatal. This study investigated the genomic and immune characteristics of tumors from women who survived more than 10 ...